Epstein Barr virus is not a characteristic feature in the central nervous system in established multiple sclerosis

Brain

Volumn 133, Issue 5, 2010, Pages

  Peferoen, Laura A N ^a   Lamers, Floris ^a   Lodder, Lenthe N R ^a   Gerritsen, Wouter H ^a   Huitinga, Inge ^b   Melief, Jeroen ^b   Giovannoni, Gavin ^c   Meier, Ute ^c   Hintzen, Rogier Q ^d   Verjans, Georges M G M ^d   Van Nierop, Gijsbert P ^d   Vos, Wim ^a   Peferoen Baert, Regina M B ^a   Middeldorp, Jaap M ^a   Van Der Valk, Paul ^a   Amor, Sandra ^a,c  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b NETHERLANDS BRAIN BANK   (Netherlands)

^c QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^d ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

B LYMPHOCYTE; CELL INFILTRATION; EPSTEIN BARR VIRUS; HUMAN; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; LETTER; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; VIRUS INFECTION;

BRAIN; EPSTEIN-BARR VIRUS INFECTIONS; HERPESVIRUS 4, HUMAN; HUMANS; MULTIPLE SCLEROSIS;

EID: 77951893380     PISSN: 00068950     EISSN: 14602156     Source Type: Journal    
DOI: 10.1093/brain/awp296     Document Type: Letter

References (13)

1. Ascherio A, Munger KL. Environmental risk factors for multiple sclerosis: Part I. The role of infection. Ann Neurol 2007; 61: 288-299 (Pubitemid 46676728)
2. Gulley ML, Tang W. Laboratory assays for Epstein-Barr virus-related disease. J Mol Diagn 2008; 10: 279-292
3. Iwakiri D, Zhou L, Samanta M, Matsumoto M, Ebihara T, Seya T, et al. Epstein-Barr virus (EBV)-encoded small RNA is released from EBV-infected cells and activates signalling from toll-like receptor 3. J Exp Med 2009; 206: 2091-2099
4. Lünemann JD, Münz C. EBV in multiple sclerosis: guilty by association? Trends Immunol, 2009, 30. 243-248
5. Marsee DK, Pinkus GS, Hornick JL. Podoplanin (D2-40) is a highly effective marker of follicular dendritic cells. Appl Immunohistochem Mol Morphol 2009; 17: 102-107
6. Middeldorp JM, Brink AA, van den Brule AJ, Meijer CJ. Pathogenic roles for Epstein-Barr virus (EBV) gene products in EBV-associated prolifera-tive disorders. Crit Rev Oncol Hematol 2003; 45: 1-36.
7. Salvetti M, Giovannoni G, Aloisi F. Epstein-Barr virus and multiple sclerosis. Curr Opin Neurol 2009; 22: 201-206
8. Serafini B, Rosicarelli B, Franciotta D, Magliozzi R, Reynolds R, Cinque P, et al. Dysregulated Epstein-Barr virus infection in the multiple sclerosis brain. J Exp Med 2007; 204: 2899-2912
9. Stevens SJ, Brink AA, Middeldorp JM. Profiling of Epstein-Barr virus latent RNA expression in clinical specimens by gene-specific multi-primed cDNA synthesis and PCR. Methods Mol Biol 2005b; 292: 27-38.
10. Stevens SJ, Verkuijlen SA, Middeldorp JM. Quantitative detection of Epstein-Barr virus DNA in clinical specimens by rapid real-time PCR targeting a highly conserved region of EBNA-1. Methods Mol Biol 2005a; 292: 15-26.
11. Webster-Cyriaque J, Middeldorp J, Raab-Traub N. Hairy leukoplakia: an unusual combination of transforming and permissive Epstein-Barr virus infections. J Virol 2000; 74: 7610-7618
12. Willis SN, Stadelmann C, Rodig SJ, Caron T, Gattenloehner S, Mallozzi SS, et al. Epstein-Barr virus infection is not a characteristic feature of multiple sclerosis brain. Brain 2009 (in press).
13. Zaadstra BM, Chorus AM, van Buuren S, Kalsbeek H, van Noort JM. Selective association of multiple sclerosis with infectious mono-nucleosis. Mult Scler 2008; 14: 307-313